A meta-analysis of 10 studies on over 268,000 subjects has determined that potassium intake is inversely related to risk of ischemic stroke.
A meta-analysis of 10 studies on over 268,000 subjects has determined that potassium intake is inversely related to risk of ischemic stroke. Results are available in the journal Stroke.
An ischemic stroke occurs when there is an obstruction to a blood vessel supplying blood to the brain. Short of identifying an exact mechanism behind potassium’s affect on the condition, researchers concluded that an 11% reduced risk of ischemic stroke for every 1000-mg/day increased.
A total of 8695 strokes were recorded throughout the 10 studies.
Previous meta-analyses support the theory of potassium affecting stroke risk. A 2011 meta-analysis published in the Journal of the American College of Cardiology found that subjects consuming the highest amounts of potassium held a 79% reduced stroke risk, compared to subjects in the lowest intake pool.
The Stroke study was led by researchers at the National Institute of Environmental Medicine (Stockholm). Funding was made available by a grant from the Karolinska Institutet and the Swedish Council for Working Life and Social Research.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.